Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
Daniele Pala, Marco Pistis
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36

Showing 26-50 of 36 citing articles:

Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry
Noam Zevit, Mirna Chehade, John Leung, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 1, pp. 143-149.e9
Open Access | Times Cited: 6
Vitamin D status in hospitalized COVID‑19 patients is associated with disease severity and IL-5 production
Yali Qiu, Wuping Bao, Xue Tian, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 2
The Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters
Milica Milentijević, Nataša Katanić, Bojan Joksimović, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1281-1281
Open Access
Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine Candidate
Tuba Çiğdem Oğuzoğlu, Alireza Hanifehnezhad, Saber Delpasand Khabbazi, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 977-977
Open Access
The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic
Sadan SOYYIGIT, Sengul BEYAZ, Zeynep CELEBI SOZENER
Asthma Allergy Immunology (2023), pp. 35-44
Open Access | Times Cited: 1
Asthma Control during COVID-19 Lockdown in Patients with Severe Asthma under Biological Drug Treatment
Corrado Pelaia, Alessandro Casarella, Gianmarco Marcianò, et al.
Applied Sciences (2021) Vol. 11, Iss. 24, pp. 12089-12089
Open Access | Times Cited: 3
A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung Disease
Yuefeng Wu, Hai Song
Life (2022) Vol. 12, Iss. 1, pp. 130-130
Open Access | Times Cited: 2
Off-Label Benralizumab in Severe Non-Necrotizing Eosinophilic Vasculitis following Critical COVID-19 Disease and in DRESS
Irena Pintea, Ioana Adriana Muntean, Carmen Teodora Dobrican, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 22, pp. 6642-6642
Open Access | Times Cited: 2
Mepolizumab as a Potential Protective Factor of COVID-19 Mortality: A Case Report of Chronic Bronchitis and Asthma in an Elderly Patient
Sanamveer S. Dhillon, Nimrit K. Toor, Maria E. Ramos‐Niño, et al.
American Journal of Case Reports (2022) Vol. 23
Open Access | Times Cited: 2
Vitamin D status in hospitalized COVID‑19 patients is associated with disease severity and IL-5 production
Yali Qiu, Wuping Bao, Xue Tian, et al.
Research Square (Research Square) (2023)
Open Access
Neutrophil and eosinophil extracellular traps in intensive care unit Covid patients' peripheral smears
Sofia Chiatamone Ranieri, Chiara Angeletti
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. 6, pp. 995-998
Closed Access
Previous Page - Page 2

Scroll to top